Navigation Links
Using magenetic nanoparticles to combat cancer
Date:7/16/2008

Scientists at Georgia Tech have developed a potential new treatment against cancer that attaches magnetic nanoparticles to cancer cells, allowing them to be captured and carried out of the body. The treatment, which has been tested in the laboratory and will now be looked at in survival studies, is detailed online in the Journal of the American Chemical Society.

"We've been able to use magnetic nanoparticles to capture free-floating cancer cells and then take them out of the body," said John McDonald, chair of the School of Biology at Georgia Tech and chief research scientist at the Ovarian Cancer Institute. "This technology may be of special importance in the treatment of ovarian cancer where the malignancy is typically spread by free-floating cancer cells released from the primary tumor into the abdominal cavity."

The idea came to the research team from the work of Ken Scarberry, a Ph.D. student in Tech's School of Chemistry and Biochemistry. Scarberry originally conceived of the idea as a means of extracting viruses and virally infected cells when his advisor, Chemistry professor John Zhang, had another idea. He asked if the technology could be applied to cancer. Scarberry suggested it might be an effective means of preventing cancer cells from spreading.

They began by testing the therapy on mice. After giving the cancer cells in the mice a fluorescent green tag and staining the magnetic nanoparticles red, they were able to apply a magnet and move the green cancer cells to the abdominal region.

"If the therapy is able to pass further tests that show it can prevent the cancer from spreading from the original tumor," Scarberry said, "it could be an important tool in cancer treatment."

This technology holds more promise than solely using antibodies to fight cancer because there seems to be less potential for the body to develop an immune response due to the unique peptide-targeting strategy, and the composition of th
'/>"/>

Contact: David Terraso
david.terraso@comm.gatech.edu
404-385-2966
Georgia Institute of Technology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Chicago-Based Speaker/Author Concurs with Research Finding of Using Journaling as a Tool to Combat Obesity and Other Health Problems
2. Kognitio CEO Offers Outsourced, Service-Based Data Warehousing as a New Approach to Large Scale Analytics
3. Using Mediasite for Lecture Capture Found to Enhance Student Performance at Penn State Milton S. Hershey Medical Center
4. TalktoaDoc.org Launch Allows Patients to Talk to Doctors Online Using a Webcam
5. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
6. NYC first: Complex aneurysm treated using new fenestrated endograft stent
7. NYU, Rutgers study shows how using mental strategies can alter the brains reward circuitry
8. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
9. A Place for Mom, Nations Largest Assisted Living and Senior Housing Referral Service Announces New Vice President of Finance
10. Nasal spray using bodys immune system provides hope of cure for common cold
11. Using Music to Ease the Pain of Labor; New CD Featuring Celine Dion, Norah Jones, Provides Soothing Songs for Delivery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswire/ ...essional cycling team dedicated to ethical sportin...ampions, announced today that it will become Team ...s Optical as a new sponsor of the team. Transition...daptive eyewear, offering the most advanced photoc...
(Date:11/27/2009)... XenaCare Holdings has announced that... Foundation, one of the largest nonprofit organiza...ealth education. , Delray...oldings, Inc. (OTCBB: XCHO), a company specializin...umer healthcare products, has announced today that...
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
(Date:11/27/2009)... Voyant Health™ announced today... licensed its TraumaCad Enterprise orthopedic temp...solution. , (PRWEB) Novem...ay that Spectrum Health (Grand Rapids, Michigan) h...mplating solution and its TraumaCad Extend workflo...
(Date:11/27/2009)... Specialist manufacturers who use med... saving millions of dollars by bringing in technol...ncreasing numbers of pro-active medical manufactur...e concept stage of their projects, ensuring that p... processes or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...r and sanitation severely limited in Lebanon due t...ncies have stepped up preparations for a coordinat...ess to health care for injured and patients with c...h attacks on July 12. WHO said it is assistin...
...t after memory begins to decline, executive functi...e progression from mild cognitive// impairment, a ...disease. Ron Petersen, M.D., Ph.D., Mayo Cli... "If someone with mild cognitive impairment start...
...ases the risk of hospitalization and death from he... absence of established// risk factors, says a stu... Association. An assistant professor of pre... in early life with hospitalization and subsequent...
... going by the current trends tobacco will probably...e almost 10 times the toll// it took in the 20th c...r of the American Cancer Society said, "In all of ...ncer, 1 in 5 death due to cancer is due to tobacco...
...hout Africa could help to avert about 5,7-million ... that was published in Public Library of Science M... 300 000 deaths and about two million new infectio... circumcision reduces male vulnerability to HIV in...
...ve birth to triplets through IVF procedure three y...ut any infertility treatments. She gave birth to t... because they're healthy and so am I," Magdaleno s...'m happy but, I don't know. I don't know how to ex...
Other Medicine News:Health News:Decline in Concentration, Decision-Making and Problem-Solving 2Health News:Tobacco Epidemic On The Rise 2Health News:Circumcision to Avert HIV Infection 2
(Date:11/27/2009)...Minn, Nov. 27 ACUO TECHNOLOGIES, d...ment software, data migration tools and services, ...nt and Trademark Office has approved a patent appl...a Computer Network." Acuo Technologies is pleased ...ctual property. In general, the granted patent app...
(Date:11/26/2009)...BURG, South Africa, Nov. 26 The 20...e Year Award in the Generic Pharmaceutical Market ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh...ar Award, the following criteria were used to benc...titors: growth strategy and implementation, degree...
(Date:11/25/2009)...Fla., Nov. 25 American...he Company") is pleased to announce that they have...ment office in Shanghai, China. ,, ASR has been...sential gateway for the development and production...for children and adults to be distributed and sold...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 1Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 1American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 3
...entative medicine doctors say they are outraged,ov...rescribing,human growth hormone to treat a hormone...BEACH, Fla., April 27, 2007 /PRNewswire/ -- The ad...enter of a recent New,York Times article about the...dicine (<a target="_blank" href=,"http://worldheal...
...: 0in 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in",a...ab-stops: list .5in; mso-list: l1 level1 lfo2">, <...othic MT,; mso-bidi-font-weight: bold">,Independen... adding,Diovan to conventional therapy , , , ,<...in; mso-list: l1 level1 lfo2">, <span style=,"FONT...
Other Medicine Technology:Doctors Outraged Over Growth Hormone Controversy 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
Blue Line® Intubation Stylet 7.5 mm 10 mm
Lighted Pediatric Stylet - Non-Sterile
Surch-Lite™ Flexible Light - 15" Non-Sterile
Peripheral Nerve Stimulator Electrodes
Medicine Products: